Literature DB >> 2091337

A randomized comparative study of artemisinine (qinghaosu) suppositories and oral quinine in acute falciparum malaria.

K Arnold1, T H Tran, T C Nguyen, H P Nguyen, P Pham.   

Abstract

In adult patients with acute falciparum malaria in Ho Chi Minh City, Vietnam, a more rapid reduction in parasite count (50% clearance in 11.3 h) and complete clearance (41.8 h) was obtained in 32 adult patients randomly assigned to received artemisinine suppositories than was obtained with 30 patients receiving oral quinine (20.8 h and 68.1 h). There were higher degrees of resistance (RII, 3 cases; RI early, 1 case) with quinine than with artemisinine but in a subgroup of patients quinine reduced parasitaemia as rapidly as artemisinine (50% clearance 13.6 h and 10.1 h respectively). Recrudescence (RI, delayed), occurred in 16 patients receiving artemisinine compared with 6 receiving quinine. Artemisinine suppositories, because of ease of administration, efficacy, and lack of side effects or risk of overdose, have advantages for the early treatment of falciparum malaria by possibly reducing the morbidity and mortality associated with a high or sustained parasitaemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091337     DOI: 10.1016/0035-9203(90)90012-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics.

Authors:  P J de Vries; N N Bich; H Van Thien; L N Hung; T K Anh; P A Kager; S H Heisterkamp
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia.

Authors:  Matthew R Hassett; Paul D Roepe
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 3.  Artemisinin derivatives for treating uncomplicated malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.

Authors:  S Q Zhang; T N Hai; K F Ilett; D X Huong; T M Davis; M Ashton
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 5.  Artemisinins.

Authors:  C J Woodrow; R K Haynes; S Krishna
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

Review 6.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

7.  Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.

Authors:  S Krudsood; K Chalermrut; C Pengruksa; S Srivilairit; U Silachamroon; S Treeprasertsuk; S Kano; G M Brittenham; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-06       Impact factor: 0.267

8.  Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.

Authors:  Nguyen Thi Hue; Jean Paul Charlieu; Tran Thi Hong Chau; Nick Day; Jeremy J Farrar; Tran Tinh Hien; Sarah J Dunstan
Journal:  Malar J       Date:  2009-07-10       Impact factor: 2.979

9.  Susceptibility of Pneumocystis carinii to artemisinin in vitro.

Authors:  S Merali; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 10.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.